{domain:"www.qualitydigest.com",server:"169.47.211.87"} Skip to main content

User account menu
Main navigation
  • Topics
    • Customer Care
    • FDA Compliance
    • Healthcare
    • Innovation
    • Lean
    • Management
    • Metrology
    • Operations
    • Risk Management
    • Six Sigma
    • Standards
    • Statistics
    • Supply Chain
    • Sustainability
    • Training
  • Videos/Webinars
    • All videos
    • Product Demos
    • Webinars
  • Advertise
    • Advertise
    • Submit B2B Press Release
    • Write for us
  • Metrology Hub
  • Training
  • Subscribe
  • Log in
Mobile Menu
  • Home
  • Topics
    • 3D Metrology-CMSC
    • Customer Care
    • FDA Compliance
    • Healthcare
    • Innovation
    • Lean
    • Management
    • Metrology
    • Operations
    • Risk Management
    • Six Sigma
    • Standards
    • Statistics
    • Supply Chain
    • Sustainability
    • Training
  • Login / Subscribe
  • More...
    • All Features
    • All News
    • All Videos
    • Contact
    • Training

CRO Completes Multinational Training Program for Principal Investigators from China, Duke University

Clinical Research Consulting Inc.
Tue, 04/22/2008 - 22:00
  • Comment
  • RSS

Social Sharing block

  • Print
Body

Lisa Mazurka and the clinical investigators involved in the training is available

(Clinical Research Consulting Inc.: Boston, Massachusetts) -- Clinical Research Consulting Inc., a contract research organization (CRO) specializing in clinical monitoring, project management, education and training, has completed training for investigators involved in an investigator-sponsored study led by Duke University in conjunction with the Beijing Cancer Hospital and Peking University. Six investigators from Beijing joined investigators and other research personnel from Duke for the one-and-a-half-day training session led by Lisa Mazurka, president of CRC.

The formal training session was conducted at the Duke Comprehensive Cancer Center, in Durham, North Carolina, and covered Food and Drug Administration regulations, good clinical practice guidelines, and additional topics that are imperative to investigators such as informed consent, investigator responsibilities, protocol compliance, adverse events, documentation, noncompliance, fraud, and FDA suspension.

 …

Want to continue?
Log in or create a FREE account.
Enter your username or email address
Enter the password that accompanies your username.
By logging in you agree to receive communication from Quality Digest. Privacy Policy.
Create a FREE account
Forgot My Password

Add new comment

Image CAPTCHA
Enter the characters shown in the image.
Please login to comment.
      

© 2025 Quality Digest. Copyright on content held by Quality Digest or by individual authors. Contact Quality Digest for reprint information.
“Quality Digest" is a trademark owned by Quality Circle Institute Inc.

footer
  • Home
  • Print QD: 1995-2008
  • Print QD: 2008-2009
  • Videos
  • Privacy Policy
  • Write for us
footer second menu
  • Subscribe to Quality Digest
  • About Us
  • Contact Us